2025年全球醫療保健總體基因體學市場報告

近年來，醫療保健領域總體基因體學的市場規模迅速擴張，從2024年的20.7億美元成長到2025年的24.4億美元，複合年成長率達17.9%。這一成長主要得益於生物資訊學工具在分析複雜元基因組數據方面的應用日益廣泛、對快速準確病原體檢測方法的需求不斷成長，以及總體基因體學在藥物發現和生物標記鑑定方面的應用日益增多。

預計未來幾年，醫療保健領域的總體基因體學市場將快速成長，到2029年市場規模將達到46.6億美元，複合年成長率（CAGR）為17.6%。預測期內的成長可歸因於感染疾病病率的上升、對精準醫療需求的增加、利用總體基因體學進行抗菌素抗藥性監測的日益重視、總體基因體學學在腫瘤研究和診斷中應用範圍的擴大，以及人們對基於微生物組的治療和干涉措施的認知不斷提高。預測期內的關鍵趨勢包括定序平台的技術進步、生物資訊學流程的創新、單細胞總體基因體學的發展、微生物組療法的研發以及人工智慧在數據分析中的應用。

在醫療保健領域，總體基因體學是指分析直接從臨床或環境樣本中獲得的遺傳物質，無需培養即可研究整個微生物群落。它有助於識別病原體、研究微生物組組成並檢測與疾病相關的微生物變化，從而實現精準診斷、個人化治療和加強感染控制。

醫療保健領域的主要總體基因體學類型包括樣本萃取試劑套件和總體基因體學套件。樣本萃取試劑套件是市售工具，旨在高效可靠地從生物樣本中分離去氧核糖核酸)或核糖核酸 (rRNA)。它們採用次世代定序、聚合酵素鏈鎖反應)和微陣列等技術，並遵循包括樣本採集、 去氧核糖核酸萃取、文庫建構和定序在內的工作流程。這些試劑盒應用於感染疾病診斷、基因組流行病學、個人化醫療、微生物組分析和藥物研發等領域，服務醫院、診斷實驗室、研究機構、製藥公司和生物技術公司等終端用戶。

美國在2025年春季突然提高關稅，由此引發的貿易摩擦對醫療保健產業造成了嚴重衝擊，尤其對關鍵醫療設備、診斷試劑和藥品的供應造成了嚴重影響。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的緊張，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為了應對這項挑戰，醫療產業正在積極調整籌資策略，盡可能地促進本地生產，並呼籲對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）最新發布的醫療保健總體基因體學市場統計系列報告之一，為您提供在醫療保健總體基因體學學行業取得成功所需的關鍵數據，包括全球醫療保健總體基因體學市場規模、區域佔有率、市場佔有率總體基因體學、詳細的市場總體基因體學、市場趨勢和商業機會。本醫療保健總體基因體學市場研究報告對該行業的現狀和未來發展趨勢進行了深入分析，為您提供全面觀點所需的一切資訊。

感染疾病日益普遍預計將推動醫療保健領域總體基因體學市場的成長。感染疾病是由有害微生物（例如細菌、病毒、真菌和寄生蟲）引起的疾病，可透過直接或間接途徑在人與人之間傳播。感染疾病流行率的上升主要是由於旅行的增加，這加速了病原體在不同地區和國家之間的傳播。總體基因體學在醫療保健領域發揮關鍵作用，它能夠快速且準確地識別病原體，從而在對抗這些疾病方面至關重要，對於控制感染疾病疫情至關重要。分析複雜的微生物群落可以減少診斷的不確定性，改善患者預後，並有助於制定標靶治療方法。例如，英國衛生安全局在2024年2月報告稱，英格蘭的結核病病例將在2023年增加10.7%，達到4850例，而2022年為4380例。因此，感染疾病日益普遍正在推動醫療保健領域總體基因體學市場的擴張。

醫療保健領域總體基因體學市場的主要企業正在開發創新解決方案，例如微生物群落分析。該技術利用定序和生物資訊工具，對給定樣本中的微生物群落進行全面分析，並評估其組成、多樣性和功能。例如，2024年8月，華大基因科技有限公司推出了人類微生物組總體基因體學定序軟體套件。該軟體包提供了一個自動化的端到端微生物群落分析工作流程，有助於分析人類微生物組的多樣性及其與各種疾病的關聯。該軟體包減少了人工操作，提高了結果的可重複性，並降低了成本，使大規模臨床微生物組研究更容易進行。研究人員受益於更快、更準確的微生物鑑定和可調整的通量，有助於生物標記的發現並推進轉化醫學研究。

2025年5月，總部位於印度的基因組學和診斷公司Mapmygenome India Limited收購了Microbiome Insights Inc.，以擴展其微生物組測序和分析能力。透過此次收購，Mapmygenome旨在加強在北美市場的地位，並提升其在個人化醫療、基因組學和研究服務方面的實力。總部位於加拿大的Microbiome Insights Inc.專注於醫療保健應用的元基因組分析。

醫療保健領域的總體基因體學市場由提供生物資訊分析、微生物診斷和藥物研發支援等服務的營業單位所獲得的收入組成。市場價值還包括服務供應商銷售的或包含在其服務產品中的相關商品的價值。醫療保健領域的總體基因體學市場還包括定序平台、試劑、耗材和生物資訊工具的銷售。該市場的價值為“出廠價”，即商品製造商或創造者銷售的商​​品價值，無論銷售對像是其他營業單位（包括下游製造商、經銷商、分銷商和零售商）還是直接銷售給最終客戶。該市場中的商品價值也包括商品創造者提供的相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球醫療保健中的總體基因體學：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 終端用戶產業分析
• 全球醫療保健總體基因體學市場：成長率分析
• 全球醫療保健總體基因體學市場表現：規模與成長，2019-2024年
• 全球醫療保健總體基因體學市場預測：規模和成長，2024-2029年，2034年預測
• 全球醫療保健總體基因體學：潛在市場規模 (TAM)

第6章 市場細分

• 總體基因體學學市場：按類型、表現和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 樣本萃取試劑套件
• 總體基因體學套件
• 全球醫療保健總體基因體學市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 次世代定序儀
• 聚合酵素鏈鎖反應
• 微陣列
• 全球醫療保健總體基因體學市場：依工作流程分類，實際數據和預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
• 樣本採集
• 去氧核糖核酸萃取
• 圖書館準備
• 定序
• 全球醫療保健總體基因體學市場：按應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 感染疾病診斷
• 基因組流行病學
• 個人化醫療
• 微生物組分析
• 藥物發現
• 總體基因體學市場：依最終用戶分類，實際數據和預測數據，2019-2024年、2024-2029年預測數據、2034年預測數據
• 醫院
• 診斷實驗室
• 研究所
• 製藥公司
• 生技公司
• 全球醫療保健總體基因體學市場：按樣本提取試劑套件、類型細分，實際值和預測值（2019-2024 年、2024-2029 年預測值、2034 年預測值）。
• 去氧核糖核酸萃取試劑套件
• 核糖核酸萃取試劑套件
• 蛋白質萃取試劑套件
• 總體基因體學市場：總體基因體學套件、類型、實際值和預測值（2019-2024 年、2024-2029 年預測值、2034 年預測值）進行細分
• 圖書館準備套件
• 定序試劑套件
• 標靶富集試劑套件

第7章 區域和國家分析

• 總體基因體學學市場：區域分析、預測與成長，2019-2024年、2024-2029年預測、2034年預測
• 總體基因體學市場：國家、表現及預測，2019-2024年、2024-2029年預測、2034年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 醫療保健領域的總體基因體學市場：競爭格局
• 醫療保健領域的總體基因體學市場：公司概況
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• QIAGEN NV
• BGI Genomics Co. Ltd.
• Novogene Corporation
• Oxford Nanopore Technologies Limited
• Pacific Biosciences of California Inc.
• MedGenome Labs Limited
• Zymo Research Corporation
• BaseClear BV
• Psomagen Inc.
• Karius Inc.
• Microsynth AG
• Macrogen Inc.
• Norgen Biotek Corp.
• Tiny Health Inc.
• CosmosID Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年醫療保健領域總體基因體學市場：提供新機會的國家
• 2029年醫療保健領域總體基因體學市場：提供新機會的細分市場
• 2029年醫療保健領域總體基因體學市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Metagenomics in healthcare is the analysis of genetic material obtained directly from clinical or environmental samples to study entire microbial communities without the need for culturing. It aids in identifying pathogens, examining microbiome composition, and detecting disease-associated microbial changes, enabling accurate diagnosis, personalized therapy, and enhanced infection management.

The main types of metagenomics in healthcare are sample extraction kits and metagenomics kits. Sample extraction kits are commercially available tools designed to efficiently and reliably isolate deoxyribonucleic acid or ribonucleic acid from biological samples. It employs technologies such as next-generation sequencing, polymerase chain reaction, and microarray, and follows workflows including sample collection, deoxyribonucleic acid extraction, library preparation, and sequencing. It is applied in infectious disease diagnosis, genomic epidemiology, personalized medicine, microbiome analysis, and drug discovery, serving end users including hospitals, diagnostic laboratories, research institutes, pharmaceutical companies, and biotechnology companies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The metagenomics in healthcare market research report is one of a series of new reports from The Business Research Company that provides metagenomics in healthcare market statistics, including metagenomics in the healthcare industry's global market size, regional shares, competitors with a metagenomics in healthcare market share, detailed metagenomics in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the metagenomics in healthcare industry. This metagenomics in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metagenomics in healthcare market size has grown rapidly in recent years. It will grow from $2.07 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to rising adoption of bioinformatics tools to analyze complex metagenomic data, increasing need for rapid and accurate pathogen detection methods, and growing use of metagenomics in drug discovery and biomarker identification.

The metagenomics in healthcare market size is expected to see rapid growth in the next few years. It will grow to $4.66 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to increasing prevalence of infectious diseases, rising demand for precision medicine, greater focus on antimicrobial resistance surveillance using metagenomics, expanding applications of metagenomics in oncology research and diagnostics, and growing awareness of microbiome-based therapies and interventions. Major trends in the forecast period include technological advancements in sequencing platforms, innovations in bioinformatics pipelines, developments in single-cell metagenomics, research and development in microbiome therapeutics, and integration of artificial intelligence in data analysis.

The increasing prevalence of infectious diseases is expected to drive the growth of the metagenomics in healthcare market. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread directly or indirectly between individuals. The rise in infectious disease prevalence is largely due to increased travel, which accelerates the spread of pathogens across regions and countries. Metagenomics in healthcare plays a crucial role in combating these diseases by enabling the rapid and accurate identification of pathogens, making it essential for managing infectious outbreaks. It reduces diagnostic uncertainty by analyzing complex microbial communities, improving patient outcomes, and facilitating targeted treatment approaches. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England rose by 10.7% in 2023, reaching 4,850 cases compared to 4,380 in 2022. Consequently, the growing prevalence of infectious diseases is driving the expansion of the metagenomics in healthcare market.

Leading companies in the metagenomics in healthcare market are developing innovative solutions, such as microbial community profiling. This method involves the comprehensive analysis of microbial populations in a specific sample, using sequencing and bioinformatics tools to assess their composition, diversity, and functional roles. For instance, in August 2024, MGI Tech Co. Ltd., a biotechnology company based in China, launched a Human Microbiome Metagenomics Sequencing Package. This package offers an automated, end-to-end workflow for microbial community profiling, making it easier to analyze human microbiome diversity and its link to various diseases. The package reduces manual labor, enhances reproducibility, and lowers costs, making large-scale and clinical microbiome research more accessible. Researchers benefit from faster and more precise microbial identification, as well as adaptable throughput, which aids in biomarker discovery and advances translational health research.

In May 2025, Mapmygenome India Limited, a genomics and diagnostics company based in India, acquired Microbiome Insights Inc. to expand its microbiome sequencing and analysis capabilities. With this acquisition, Mapmygenome aims to strengthen its presence in the North American market and enhance its offerings in personalized health, genomics, and research services. Microbiome Insights Inc., based in Canada, specializes in metagenomics for healthcare applications.

Major players in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., and Wobble Genomics Inc.

North America was the largest region in the metagenomics in healthcare market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in metagenomics in healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metagenomics in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metagenomics in healthcare market consists of revenues earned by entities by providing services such as bioinformatics analysis, microbial diagnostics, and drug discovery support. The market value includes the value of related goods sold by the service provider or included within the service offering. The metagenomics in the healthcare market also includes sales of sequencing platforms, reagents, consumables, and bioinformatics tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metagenomics In Healthcare Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metagenomics in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metagenomics in healthcare ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The metagenomics in healthcare market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Types: Sample Extraction Kits; Metagenomics Kits
• 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray
• 3) By Workflow: Sample Collection; Deoxyribonucleic Acid Extraction; Library Preparation; Sequencing
• 4) By Application: Infectious Disease Diagnosis; Genomic Epidemiology; Personalized Medicine; Microbiome Analysis; Drug Discovery
• 5) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical Companies; Biotechnology Companies
• Subsegments:
• 1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits; Ribonucleic Acid Extraction Kits; Protein Extraction Kits
• 2) By Metagenomics Kits: Library Preparation Kits; Sequencing Kits; Target Enrichment Kits
• Companies Mentioned: F. Hoffmann-La Roche AG; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; BGI Genomics Co. Ltd.; Novogene Corporation; Oxford Nanopore Technologies Limited; Pacific Biosciences of California Inc.; MedGenome Labs Limited; Zymo Research Corporation; BaseClear B.V.; Psomagen Inc.; Karius Inc.; Microsynth AG; Macrogen Inc.; Norgen Biotek Corp.; Tiny Health Inc.; CosmosID Inc.; Kanvas Biosciences Inc.; Phase Genomics Inc.; Wobble Genomics Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Metagenomics In Healthcare Market Characteristics

3. Metagenomics In Healthcare Market Trends And Strategies

4. Metagenomics In Healthcare Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Metagenomics In Healthcare Growth Analysis And Strategic Analysis Framework

• 5.1. Global Metagenomics In Healthcare PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Metagenomics In Healthcare Market Growth Rate Analysis
• 5.4. Global Metagenomics In Healthcare Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Metagenomics In Healthcare Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Metagenomics In Healthcare Total Addressable Market (TAM)

6. Metagenomics In Healthcare Market Segmentation

• 6.1. Global Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Extraction Kits
• Metagenomics Kits
• 6.2. Global Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microarray
• 6.3. Global Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sample Collection
• Deoxyribonucleic Acid Extraction
• Library Preparation
• Sequencing
• 6.4. Global Metagenomics In Healthcare Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infectious Disease Diagnosis
• Genomic Epidemiology
• Personalized Medicine
• Microbiome Analysis
• Drug Discovery
• 6.5. Global Metagenomics In Healthcare Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical Companies
• Biotechnology Companies
• 6.6. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Sample Extraction Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid Extraction Kits
• Ribonucleic Acid Extraction Kits
• Protein Extraction Kits
• 6.7. Global Metagenomics In Healthcare Market, Sub-Segmentation Of Metagenomics Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Library Preparation Kits
• Sequencing Kits
• Target Enrichment Kits

7. Metagenomics In Healthcare Market Regional And Country Analysis

• 7.1. Global Metagenomics In Healthcare Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Metagenomics In Healthcare Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metagenomics In Healthcare Market

• 8.1. Asia-Pacific Metagenomics In Healthcare Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metagenomics In Healthcare Market

• 9.1. China Metagenomics In Healthcare Market Overview
• 9.2. China Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metagenomics In Healthcare Market

• 10.1. India Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metagenomics In Healthcare Market

• 11.1. Japan Metagenomics In Healthcare Market Overview
• 11.2. Japan Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metagenomics In Healthcare Market

• 12.1. Australia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metagenomics In Healthcare Market

• 13.1. Indonesia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metagenomics In Healthcare Market

• 14.1. South Korea Metagenomics In Healthcare Market Overview
• 14.2. South Korea Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metagenomics In Healthcare Market

• 15.1. Western Europe Metagenomics In Healthcare Market Overview
• 15.2. Western Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metagenomics In Healthcare Market

• 16.1. UK Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metagenomics In Healthcare Market

• 17.1. Germany Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metagenomics In Healthcare Market

• 18.1. France Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metagenomics In Healthcare Market

• 19.1. Italy Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metagenomics In Healthcare Market

• 20.1. Spain Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metagenomics In Healthcare Market

• 21.1. Eastern Europe Metagenomics In Healthcare Market Overview
• 21.2. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metagenomics In Healthcare Market

• 22.1. Russia Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metagenomics In Healthcare Market

• 23.1. North America Metagenomics In Healthcare Market Overview
• 23.2. North America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metagenomics In Healthcare Market

• 24.1. USA Metagenomics In Healthcare Market Overview
• 24.2. USA Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metagenomics In Healthcare Market

• 25.1. Canada Metagenomics In Healthcare Market Overview
• 25.2. Canada Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metagenomics In Healthcare Market

• 26.1. South America Metagenomics In Healthcare Market Overview
• 26.2. South America Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metagenomics In Healthcare Market

• 27.1. Brazil Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metagenomics In Healthcare Market

• 28.1. Middle East Metagenomics In Healthcare Market Overview
• 28.2. Middle East Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metagenomics In Healthcare Market

• 29.1. Africa Metagenomics In Healthcare Market Overview
• 29.2. Africa Metagenomics In Healthcare Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Metagenomics In Healthcare Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Metagenomics In Healthcare Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metagenomics In Healthcare Market Competitive Landscape And Company Profiles

• 30.1. Metagenomics In Healthcare Market Competitive Landscape
• 30.2. Metagenomics In Healthcare Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Metagenomics In Healthcare Market Other Major And Innovative Companies

• 31.1. QIAGEN N.V.
• 31.2. BGI Genomics Co. Ltd.
• 31.3. Novogene Corporation
• 31.4. Oxford Nanopore Technologies Limited
• 31.5. Pacific Biosciences of California Inc.
• 31.6. MedGenome Labs Limited
• 31.7. Zymo Research Corporation
• 31.8. BaseClear B.V.
• 31.9. Psomagen Inc.
• 31.10. Karius Inc.
• 31.11. Microsynth AG
• 31.12. Macrogen Inc.
• 31.13. Norgen Biotek Corp.
• 31.14. Tiny Health Inc.
• 31.15. CosmosID Inc.

32. Global Metagenomics In Healthcare Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metagenomics In Healthcare Market

34. Recent Developments In The Metagenomics In Healthcare Market

35. Metagenomics In Healthcare Market High Potential Countries, Segments and Strategies

• 35.1 Metagenomics In Healthcare Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Metagenomics In Healthcare Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Metagenomics In Healthcare Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer